BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19276863)

  • 1. Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells.
    Ledezma E; Wittig O; Alonso J; Cardier JE
    Melanoma Res; 2009 Apr; 19(2):69-74. PubMed ID: 19276863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry.
    Yasuda N; Matzno S; Iwano C; Nishikata M; Matsuyama K
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):712-7. PubMed ID: 15927433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic and anti-adhesion effect of ajoene, a garlic derived compound, on the murine melanoma B16F10 cells: possible role of caspase-3 and the alpha(4)beta(1) integrin.
    Ledezma E; Apitz-Castro R; Cardier J
    Cancer Lett; 2004 Mar; 206(1):35-41. PubMed ID: 15019157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins induce differentiation and cell death in neurons and astroglia.
    März P; Otten U; Miserez AR
    Glia; 2007 Jan; 55(1):1-12. PubMed ID: 16998865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
    Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
    J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the factors modulating the effect of statins on malignant cell proliferation.
    Bessler H; Salman H; Bergman M; Djaldetti M
    Cancer Invest; 2007 Aug; 25(5):279-84. PubMed ID: 17661201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis.
    Schulz JG; Bösel J; Stoeckel M; Megow D; Dirnagl U; Endres M
    J Neurochem; 2004 Apr; 89(1):24-32. PubMed ID: 15030386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
    Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
    Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
    Fromigué O; Hamidouche Z; Marie PJ
    J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro.
    Salman H; Bergman M; Djaldetti M; Bessler H
    Biomed Pharmacother; 2008 Jan; 62(1):41-5. PubMed ID: 17768028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.
    Hausding M; Witteck A; Rodriguez-Pascual F; von Eichel-Streiber C; Förstermann U; Kleinert H
    Br J Pharmacol; 2000 Oct; 131(3):553-61. PubMed ID: 11015307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
    Boerma M; Burton GR; Wang J; Fink LM; McGehee RE; Hauer-Jensen M
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):173-80. PubMed ID: 16575254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric evaluation of synergistic pro-apoptotic effects of statins and clofibrates in IM-9 human lymphoblasts.
    Tomiyama N; Yasuda N; Iwano C; Matzno S; Matsuyama K
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):876-80. PubMed ID: 17645633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
    Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
    Ajith TA; Anu V; Riji T
    J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
    Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
    Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.